malaria

Tech billionaire and philanthropist Bill Gates has revealed a comprehensive strategy aimed at eradicating malaria, a disease that has plagued humanity for centuries. Gates’ plan includes several groundbreaking technologies and innovations. What Happened: Last month, in a post on his blog,...

On Tuesday, Alyssa Vance, a poster on X.com, formerly Twitter, highlighted an opportunity for individuals to participate in a human challenge trial aimed at combating malaria. What Happened: Vance took to Twitter to share information about a human challenge trial where participants can earn $5,400...

Some elements of this story have been previously reported by Benzinga and it has been updated. In a memorable and unconventional move during a 2009 TED talk on malaria prevention, Microsoft founder Bill Gates released a swarm of mosquitoes into the unsuspecting audience, saying, "There's...

Atreca Inc (NASDAQ: BCEL) has entered into a licensing agreement with the Bill & Melinda Gates Medical Research Institute to develop MAM01/ATRC-501 to prevent malaria.  MAM01/ATRC-501 is a monoclonal antibody entering preclinical development. Under the agreement, Gates MRI...

BioNTech SE (NASDAQ: BNTX) is looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal. The Company said that future malaria and tuberculosis vaccines would be based on the so-called messenger RNA technology used in its COVID-19 shot. BioNTech...

BioNTech SE (NASDAQ: BNTX) has announced that it plans to develop an mRNA-based vaccine to prevent Malaria, a mosquito-borne illness. The Company aims to begin clinical trials for the shot by the end of 2022. BioNTech said it would assess multiple vaccine candidates that target the...

Novavax Inc (NASDAQ: NVAX) has announced the pre-print publication of data from a Phase 2b trial in children evaluating its malaria vaccine candidate, R21, created by the University of Oxford. The three arms study recruited 450 participants. The vaccine includes Novavax'...